Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Update

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 52,840 shares, a growth of 391.6% from the April 15th total of 10,749 shares. Based on an average daily volume of 48,017 shares, the days-to-cover ratio is currently 1.1 days. Approximately 16.0% of the company’s shares are short sold.

Defiance Daily Target 2X Long LMND ETF Trading Up 2.2%

Defiance Daily Target 2X Long LMND ETF stock traded up $0.26 during trading on Thursday, hitting $12.06. The company’s stock had a trading volume of 11,224 shares, compared to its average volume of 47,858. The stock’s fifty day moving average is $16.70 and its 200 day moving average is $26.78. Defiance Daily Target 2X Long LMND ETF has a 1-year low of $11.46 and a 1-year high of $55.00. The stock has a market capitalization of $3.98 million, a price-to-earnings ratio of 23.65 and a beta of -10.46. The company has a debt-to-equity ratio of 0.52, a quick ratio of 6.08 and a current ratio of 8.37.

About Defiance Daily Target 2X Long LMND ETF

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.